Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder

par Inoue T, Kimura T, Inagaki Y, Shirakawa O
Publié 2020

Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database

par Inoue T, Sano H, Kojima Y, Yamada S, Shirakawa O
Publié 2021

Discrepancies between self- and observer-rated depression severities in patients with major depressive disorder associated with frequent emotion-oriented coping responses and hopel...

par Tsujimoto E, Tsujii N, Mikawa W, Ono H, Shirakawa O
Publié 2018

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder

par Harada E, Shirakawa O, Satoi Y, Marangell LB, Escobar R
Publié 2016

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population

par Otsuka I, Watanabe Y, Hishimoto A, Boku S, Mouri K, Shiroiwa K, Okazaki S, Nunokawa A, Shirakawa O, Someya T, Sora I
Publié 2015

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population

par Shimmyo N, Hishimoto A, Otsuka I, Okazaki S, Boku S, Mouri K, Horai T, Takahashi M, Ueno Y, Shirakawa O, Sora I
Publié 2017